| Moderna (MRNA) |
United States |
$170.876B |
52.78 |
| Bristol Myers Squibb (BMY) |
United States |
$134.438B |
8.95 |
| Amgen (AMGN) |
United States |
$122.151B |
13.23 |
| CSL (CSLLY) |
Australia |
$100.620B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$88.970B |
8.60 |
| BioNTech SE (BNTX) |
Germany |
$82.216B |
17.74 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$68.547B |
11.77 |
| Illumina (ILMN) |
United States |
$64.255B |
73.00 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$48.168B |
18.72 |
| Biogen (BIIB) |
United States |
$44.485B |
12.21 |
| BeiGene (BGNE) |
Cayman Islands |
$37.075B |
0.00 |
| Seagen (SGEN) |
United States |
$28.939B |
48.79 |
| Genmab (GNMSF) |
Denmark |
$28.431B |
71.07 |
| Genmab (GMAB) |
Denmark |
$28.203B |
69.26 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$24.401B |
23.13 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$23.483B |
50.05 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$21.804B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$20.666B |
92.94 |
| Exact Sciences (EXAS) |
United States |
$18.080B |
0.00 |
| Novavax (NVAX) |
United States |
$16.902B |
0.00 |
| Repligen (RGEN) |
United States |
$16.804B |
128.05 |
| Incyte (INCY) |
United States |
$16.764B |
39.74 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$16.101B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$14.188B |
101.82 |
| Guardant Health (GH) |
United States |
$13.084B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$12.471B |
21.12 |
| Zai Lab (ZLAB) |
China |
$11.835B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$10.903B |
0.00 |
| CureVac (CVAC) |
Germany |
$9.962B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$9.161B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$8.889B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$8.875B |
22.79 |
| Biohaven Pharmaceutical Holding (BHVN) |
United States |
$8.670B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$8.499B |
0.00 |
| SWEDISH ORP BIO (BIOVF) |
Sweden |
$8.417B |
30.17 |
| Sarepta Therapeutics (SRPT) |
United States |
$6.840B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$6.542B |
0.00 |
| Vir Biotechnology (VIR) |
United States |
$6.491B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$6.396B |
0.00 |
| Legend Biotech (LEGN) |
United States |
$6.392B |
0.00 |
| Beam Therapeutics (BEAM) |
United States |
$6.324B |
0.00 |
| Exelixis (EXEL) |
United States |
$6.244B |
68.35 |
| Blueprint Medicines (BPMC) |
United States |
$6.161B |
17.39 |
| Denali Therapeutics (DNLI) |
United States |
$6.065B |
171.93 |
| Halozyme Therapeutics (HALO) |
United States |
$5.868B |
23.97 |
| NeoGenomics (NEO) |
United States |
$5.780B |
783.33 |
| AbCellera Biologics (ABCL) |
|
$5.755B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$5.621B |
0.00 |
| I-Mab (IMAB) |
China |
$5.566B |
0.00 |
| Certara (CERT) |
United States |
$5.415B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$5.308B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$4.779B |
141.05 |
| Arvinas (ARVN) |
United States |
$4.540B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$3.973B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$3.885B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$3.656B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$3.593B |
0.00 |
| SpringWorks Therapeutics (SWTX) |
United States |
$3.500B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$3.484B |
0.00 |
| Prothena (PRTA) |
Ireland |
$3.305B |
0.00 |
| Kymera Therapeutics (KYMR) |
United States |
$3.087B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$3.027B |
7.30 |
| Insmed (INSM) |
United States |
$2.998B |
0.00 |
| ALX Oncology Holdings (ALXO) |
United States |
$2.997B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$2.927B |
0.00 |
| Apellis Pharmaceuticals (APLS) |
United States |
$2.876B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$2.871B |
0.00 |
| Cytokinetics (CYTK) |
United States |
$2.708B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$2.684B |
0.00 |
| Heska (HSKA) |
United States |
$2.647B |
507.49 |
| Instil Bio (TIL) |
United States |
$2.616B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$2.596B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$2.507B |
0.00 |
| Atea Pharmaceuticals (AVIR) |
United States |
$2.396B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$2.378B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$2.376B |
0.00 |
| C4 Therapeutics (CCCC) |
United States |
$2.358B |
0.00 |
| Morphic Holding (MORF) |
United States |
$2.329B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$2.280B |
33.34 |
| Vericel (VCEL) |
United States |
$2.238B |
266.67 |
| Seer (SEER) |
|
$2.200B |
0.00 |
| Harmony Biosciences Holdings (HRMY) |
United States |
$2.125B |
36.19 |
| Alector (ALEC) |
United States |
$2.084B |
0.00 |
| Amarin (AMRN) |
Ireland |
$2.008B |
508.00 |
| Revance Therapeutics (RVNC) |
United States |
$1.977B |
0.00 |
| ADC Therapeutics SA (ADCT) |
Switzerland |
$1.946B |
0.00 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$1.870B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.857B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$1.855B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$1.722B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$1.718B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$1.712B |
0.00 |
| Berkeley Lights (BLI) |
United States |
$1.701B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$1.691B |
0.00 |
| UniQure (QURE) |
Netherlands |
$1.687B |
5.74 |
| PHARMA MAR SA (PHMMF) |
Spain |
$1.677B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$1.639B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.618B |
0.00 |
| Codexis (CDXS) |
United States |
$1.606B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$1.534B |
0.00 |
| PureTech Health (PRTC) |
United States |
$1.516B |
0.00 |
| Immunocore Holdings (IMCR) |
United Kingdom |
$1.515B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$1.510B |
0.00 |
| Ocugen (OCGN) |
United States |
$1.479B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$1.477B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$1.443B |
0.00 |
| Nurix Therapeutics (NRIX) |
United States |
$1.424B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.393B |
0.00 |
| MaxCyte (MXCT) |
United States |
$1.377B |
0.00 |
| Agenus (AGEN) |
United States |
$1.357B |
0.00 |
| Y-mAbs Therapeutics (YMAB) |
United States |
$1.356B |
0.00 |
| Inhibrx (INBX) |
United States |
$1.350B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.349B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$1.348B |
0.00 |
| Arcturus Therapeutics Holdings (ARCT) |
United States |
$1.332B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.330B |
0.00 |
| Genetron Holdings (GTH) |
China |
$1.296B |
0.00 |
| Fulcrum Therapeutics (FULC) |
United States |
$1.248B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$1.232B |
251.00 |
| Bluebird Bio (BLUE) |
United States |
$1.214B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$1.175B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$1.130B |
0.00 |
| Precigen (PGEN) |
United States |
$1.124B |
0.00 |
| MannKind (MNKD) |
United States |
$1.118B |
0.00 |
| Forma Therapeutics Holdings (FMTX) |
United States |
$1.104B |
0.00 |
| BioAtla (BCAB) |
United States |
$1.091B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$1.072B |
0.00 |
| RAPT THERAPTICS (RAPT) |
United States |
$1.059B |
0.00 |
| ImmunityBio (IBRX) |
United States |
$1.054B |
0.00 |
| Repare Therapeutics (RPTX) |
Canada |
$1.051B |
0.00 |
| Absci (ABSI) |
United States |
$1.015B |
0.00 |
| IDEAYA Biosciences (IDYA) |
United States |
$1.008B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$0.997B |
0.00 |
| Nkarta (NKTX) |
United States |
$0.988B |
0.00 |
| Prometheus Biosciences (RXDX) |
United States |
$0.960B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.917B |
28.43 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.914B |
0.00 |
| Avidity Biosciences (RNA) |
United States |
$0.895B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.887B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.884B |
0.00 |
| Immatics (IMTX) |
Germany |
$0.856B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.806B |
0.00 |
| Shattuck Labs (STTK) |
United States |
$0.800B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.793B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.767B |
95.69 |
| Mesoblast (MESO) |
Australia |
$0.762B |
0.00 |
| Amryt Pharma (AMYT) |
United Kingdom |
$0.744B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.739B |
0.00 |
| Curis (CRIS) |
United States |
$0.730B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.729B |
0.00 |
| Akoya Biosciences (AKYA) |
United States |
$0.716B |
0.00 |
| Keros Therapeutics (KROS) |
United States |
$0.683B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$0.680B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.676B |
12.32 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.668B |
0.00 |
| MiMedx (MDXG) |
United States |
$0.657B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$0.645B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.642B |
6.47 |
| Adagene (ADAG) |
China |
$0.641B |
0.00 |
| G1 THERAPEUTICS (GTHX) |
United States |
$0.639B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.637B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.619B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.618B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.616B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.614B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.612B |
24.44 |
| Spero Therapeutics (SPRO) |
United States |
$0.611B |
0.00 |
| Pharming Group (PHAR) |
Netherlands |
$0.609B |
0.00 |
| BeyondSpring (BYSI) |
United States |
$0.601B |
0.00 |
| Acumen Pharmaceuticals (ABOS) |
United States |
$0.597B |
0.00 |
| ALBIREO PHARMA (ALBO) |
United States |
$0.585B |
0.00 |
| Gritstone Bio (GRTS) |
United States |
$0.584B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.571B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.564B |
0.00 |
| Epizyme (EPZM) |
United States |
$0.561B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.558B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.557B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.541B |
0.00 |
| Inventiva S.A (IVA) |
France |
$0.541B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.540B |
0.00 |
| Vaccitech (VACC) |
United Kingdom |
$0.537B |
0.00 |
| Ambrx Biopharma (AMAM) |
United States |
$0.527B |
0.00 |
| Bolt Biotherapeutics (BOLT) |
United States |
$0.519B |
0.00 |
| Brooklyn ImmunoTherapeutics (BTX) |
United States |
$0.515B |
0.00 |
| Verastem (VSTM) |
United States |
$0.508B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$0.504B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.494B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.488B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.480B |
0.00 |
| Cel-Sci (CVM) |
United States |
$0.480B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.465B |
0.00 |
| XBiotech (XBIT) |
United States |
$0.459B |
0.00 |
| Clene (CLNN) |
United States |
$0.457B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.454B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.443B |
0.00 |
| Geron (GERN) |
United States |
$0.436B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.426B |
0.00 |
| Codiak BioSciences (CDAK) |
United States |
$0.426B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.425B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.417B |
0.00 |
| SQZ Biotechnologies (SQZ) |
United States |
$0.405B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.398B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.397B |
0.00 |
| Lineage Cell Therapeutics (LCTX) |
United States |
$0.394B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.392B |
0.00 |
| ProQR Therapeutics (PRQR) |
Netherlands |
$0.385B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.384B |
11.79 |
| Clearside Biomedical (CLSD) |
United States |
$0.378B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.374B |
10.21 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.373B |
0.00 |
| KaloBios Pharmaceuticals (HGEN) |
United States |
$0.372B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.366B |
0.00 |
| Athenex (ATNX) |
United States |
$0.365B |
0.00 |
| Cogent Biosciences (COGT) |
United States |
$0.351B |
0.00 |
| Cybin (CYBN) |
Canada |
$0.342B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.338B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.333B |
0.00 |
| Opthea (OPT) |
Australia |
$0.332B |
0.00 |
| Neoleukin Therapeutics (NLTX) |
United States |
$0.330B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.319B |
0.00 |
| Athersys (ATHX) |
United States |
$0.314B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$0.313B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.310B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.308B |
0.00 |
| INmune Bio (INMB) |
United States |
$0.307B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.305B |
0.00 |
| Angion Biomedica (ANGN) |
United States |
$0.294B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.286B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.284B |
0.00 |
| Beyond Air (XAIR) |
United States |
$0.281B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.271B |
0.00 |
| XOMA (XOMA) |
United States |
$0.270B |
113.71 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.263B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.261B |
0.00 |
| Frequency Therapeutics (FREQ) |
United States |
$0.249B |
0.00 |
| IBio (IBIO) |
United States |
$0.248B |
0.00 |
| Kaleido Biosciences (KLDO) |
|
$0.240B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.236B |
19.63 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.232B |
0.00 |
| OVID THERAPEUTC (OVID) |
United States |
$0.227B |
1.99 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.227B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.220B |
0.00 |
| Adicet Bio (ACET) |
United States |
$0.219B |
0.00 |
| Trevena (TRVN) |
United States |
$0.206B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.196B |
0.00 |
| Seelos Therapeutics (SEEL) |
United States |
$0.194B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.194B |
0.00 |
| NextCure (NXTC) |
United States |
$0.190B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.187B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.184B |
0.00 |
| Talis Biomedical (TLIS) |
United States |
$0.183B |
0.00 |
| ObsEva SA (OBSV) |
Switzerland |
$0.178B |
0.00 |
| Erytech Pharma SA (ERYP) |
France |
$0.177B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.173B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.173B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.171B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.171B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.168B |
49.43 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.166B |
0.00 |
| Leap Therapeutics (LPTX) |
United States |
$0.165B |
0.00 |
| VolitionRX (VNRX) |
United States |
$0.164B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.163B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.161B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.160B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.158B |
0.00 |
| Galena Biopharma (SLS) |
United States |
$0.155B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.154B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.153B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.152B |
0.00 |
| TScan Therapeutics (TCRX) |
United States |
$0.150B |
0.00 |
| F-star Therapeutics (FSTX) |
United Kingdom |
$0.149B |
0.00 |
| LogicBio Therapeutics (LOGC) |
United States |
$0.143B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.142B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.142B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.141B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.140B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.140B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.138B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.135B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.134B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.133B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.131B |
0.00 |
| X4 Pharmaceuticals (XFOR) |
United States |
$0.127B |
0.00 |
| Purple Biotech (PPBT) |
Israel |
$0.123B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.122B |
0.00 |
| Evofem Biosciences (EVFM) |
United States |
$0.121B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.121B |
246.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.120B |
0.00 |
| Exicure (XCUR) |
United States |
$0.117B |
0.00 |
| Eyenovia (EYEN) |
United States |
$0.115B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.115B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.113B |
6.46 |
| Entera Bio (ENTX) |
Israel |
$0.110B |
0.00 |
| Yumanity Therapeutics (YMTX) |
United States |
$0.109B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.103B |
0.00 |
| Palatin Technologies (PTN) |
United States |
$0.103B |
0.00 |
| Viridian Therapeutics (VRDN) |
United States |
$0.102B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.099B |
0.00 |
| Armata Pharmaceuticals (ARMP) |
United States |
$0.093B |
0.00 |
| Aadi Bioscience (AADI) |
United States |
$0.092B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.092B |
0.00 |
| Celsion (CLSN) |
United States |
$0.088B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.085B |
0.00 |
| Lumos Pharma (LUMO) |
United States |
$0.083B |
0.00 |
| Adocia (ADOCY) |
France |
$0.083B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.082B |
0.00 |
| Zosano Pharma (ZSAN) |
United States |
$0.080B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.080B |
0.00 |
| Stealth BioTherapeutics (MITO) |
Cayman Islands |
$0.076B |
0.00 |
| Aytu BioPharma (AYTU) |
United States |
$0.076B |
0.00 |
| Liminal BioSciences (LMNL) |
Canada |
$0.075B |
0.00 |
| Statera Biopharma (STAB) |
United States |
$0.075B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.073B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.073B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.072B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.072B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.070B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.067B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.067B |
0.00 |
| Longeveron (LGVN) |
United States |
$0.067B |
0.00 |
| AIkido Pharma (AIKI) |
United States |
$0.066B |
0.00 |
| Vyant Bio (VYNT) |
United States |
$0.066B |
0.00 |
| ABVC BioPharma (ABVC) |
United States |
$0.061B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.061B |
0.00 |
| Protalix BioTherapeutics (PLX) |
Israel |
$0.060B |
0.00 |
| Enveric Biosciences (ENVB) |
United States |
$0.054B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.054B |
0.00 |
| AnPac Bio-Medical Science (ANPC) |
China |
$0.053B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.051B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.051B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.051B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.049B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.049B |
1.01 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.048B |
0.00 |
| Forte Biosciences (FBRX) |
United States |
$0.047B |
0.00 |
| ARIDIS PHARMACT (ARDS) |
United States |
$0.046B |
0.00 |
| Vallon Pharmaceuticals (VLON) |
United States |
$0.045B |
0.00 |
| ZIVO Bioscience (ZIVO) |
United States |
$0.043B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.043B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.041B |
0.00 |
| Cyclo Therapeutics (CYTH) |
United States |
$0.040B |
0.00 |
| Invo BioScience (INVO) |
United States |
$0.035B |
0.00 |
| PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.034B |
0.00 |
| Palisade Bio (PALI) |
United States |
$0.033B |
0.00 |
| Timber Pharmaceuticals (TMBR) |
United States |
$0.033B |
0.00 |
| Lexaria Bioscience (LEXX) |
Canada |
$0.033B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.032B |
0.00 |
| Benitec Biopharma (BNTC) |
United States |
$0.029B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.029B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.029B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.028B |
0.00 |
| GeoVax Labs (GOVX) |
United States |
$0.027B |
0.00 |
| ThermoGenesis Holdings (THMO) |
United States |
$0.026B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.019B |
0.00 |
| Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.015B |
0.00 |
| CollPlant Biotechnologies (CLGN) |
Israel |
$0.000B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.000B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.000B |
0.00 |
